Skip to menu Skip to content Skip to footer

2020

Journal Article

Bariatric surgery in obese patients with ventricular assist devices

daSilva-deAbreu, Adrian, Alhafez, Bader Aldeen, Curbelo-Pena, Yuhamy, Lavie, Carl J., Ventura, Hector O., Loro-Ferrer, Juan Francisco and Mandras, Stacy A. (2020). Bariatric surgery in obese patients with ventricular assist devices. BMC Research Notes, 13 (1) 382, 382. doi: 10.1186/s13104-020-05221-z

Bariatric surgery in obese patients with ventricular assist devices

2020

Journal Article

Do genetic polymorphisms in angiotensin converting enzyme 2 (ACE2) gene play a role in coronavirus disease 2019 (COVID-19)?

Lippi, Giuseppe, Lavie, Carl J., Henry, Brandon M. and Sanchis-Gomar, Fabian (2020). Do genetic polymorphisms in angiotensin converting enzyme 2 (ACE2) gene play a role in coronavirus disease 2019 (COVID-19)?. Clinical Chemistry and Laboratory Medicine, 58 (9), 1415-1422. doi: 10.1515/cclm-2020-0727

Do genetic polymorphisms in angiotensin converting enzyme 2 (ACE2) gene play a role in coronavirus disease 2019 (COVID-19)?

2020

Journal Article

Famotidine Against SARS-CoV2: A Hope or Hype?

Ghosh, Ritwik, Chatterjee, Subhankar, Dubey, Souvik and Lavie, Carl J. (2020). Famotidine Against SARS-CoV2: A Hope or Hype?. Mayo Clinic Proceedings, 95 (8), 1797-1799. doi: 10.1016/j.mayocp.2020.05.027

Famotidine Against SARS-CoV2: A Hope or Hype?

2020

Journal Article

Impact of obesity on adverse in-hospital outcomes in patients undergoing percutaneous mitral valve edge-to-edge repair using MitraClip® procedure - Results from the German nationwide inpatient sample

Keller, Karsten, Hobohm, Lukas, Geyer, Martin, Kreidel, Felix, Ostad, Mir A., Lavie, Carl J., Lankeit, Mareike, Konstantinides, Stavros, Münzel, Thomas and von Bardeleben, Ralph Stephan (2020). Impact of obesity on adverse in-hospital outcomes in patients undergoing percutaneous mitral valve edge-to-edge repair using MitraClip® procedure - Results from the German nationwide inpatient sample. Nutrition, Metabolism and Cardiovascular Diseases, 30 (8), 1365-1374. doi: 10.1016/j.numecd.2020.04.009

Impact of obesity on adverse in-hospital outcomes in patients undergoing percutaneous mitral valve edge-to-edge repair using MitraClip® procedure - Results from the German nationwide inpatient sample

2020

Journal Article

Pharmaco-immunomodulatory therapy in COVID-19

Rizk, John G., Kalantar-Zadeh, Kamyar, Mehra, Mandeep R., Lavie, Carl J., Rizk, Youssef and Forthal, Donald N. (2020). Pharmaco-immunomodulatory therapy in COVID-19. Drugs, 80 (13), 1267-1292. doi: 10.1007/s40265-020-01367-z

Pharmaco-immunomodulatory therapy in COVID-19

2020

Journal Article

The Journal of Cardiopulmonary Rehabilitation and Prevention at 40 yr and its role in promoting preventive cardiology: part 2

Franklin, Barry A., Brubaker, Peter, Harber, Matthew P., Lavie, Carl J., Myers, Jonathan and Kaminsky, Leonard A. (2020). The Journal of Cardiopulmonary Rehabilitation and Prevention at 40 yr and its role in promoting preventive cardiology: part 2. Journal of Cardiopulmonary Rehabilitation and Prevention, 40 (4), 209-214. doi: 10.1097/HCR.0000000000000523

The Journal of Cardiopulmonary Rehabilitation and Prevention at 40 yr and its role in promoting preventive cardiology: part 2

2020

Journal Article

Statistics 2020 at progress in cardiovascular diseases

Lavie, Carl J. (2020). Statistics 2020 at progress in cardiovascular diseases. Progress in Cardiovascular Diseases, 63 (4), 534-535. doi: 10.1016/j.pcad.2020.07.008

Statistics 2020 at progress in cardiovascular diseases

2020

Journal Article

Editorial: Hypertension in special populations and the role in comoborbities

Ventura, Hector O. and Lavie, Carl J. (2020). Editorial: Hypertension in special populations and the role in comoborbities. Current Opinion in Cardiology, 35 (4), 341-341. doi: 10.1097/HCO.0000000000000747

Editorial: Hypertension in special populations and the role in comoborbities

2020

Journal Article

In reply—Angiotensin-converting enzyme 2 and the resolution of inflammation: In support of continuation of prescribed angiotensin-converting enzyme inhibitors and angiotensin receptor blockers

Sanchis-Gomar, Fabian, Lavie, Carl J., Perez-Quilis, Carme, Henry, Brandon M. and Lippi, Giuseppe (2020). In reply—Angiotensin-converting enzyme 2 and the resolution of inflammation: In support of continuation of prescribed angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. Mayo Clinic Proceedings, 95 (7), 1553-1556. doi: 10.1016/j.mayocp.2020.05.003

In reply—Angiotensin-converting enzyme 2 and the resolution of inflammation: In support of continuation of prescribed angiotensin-converting enzyme inhibitors and angiotensin receptor blockers

2020

Journal Article

Hypertension in obesity

Mendoza, Michael F., Kachur, Sergey M. and Lavie, Carl J. (2020). Hypertension in obesity. Current Opinion in Cardiology, 35 (4), 389-396. doi: 10.1097/HCO.0000000000000749

Hypertension in obesity

2020

Journal Article

Obesity and outcomes in COVID-19: when an epidemic and pandemic collide

Sanchis-Gomar, Fabian, Lavie, Carl J., Mehra, Mandeep R., Henry, Brandon Michael and Lippi, Giuseppe (2020). Obesity and outcomes in COVID-19: when an epidemic and pandemic collide. Mayo Clinic Proceedings, 95 (7), 1445-1453. doi: 10.1016/j.mayocp.2020.05.006

Obesity and outcomes in COVID-19: when an epidemic and pandemic collide

2020

Journal Article

SGLT2 inhibition, visceral adiposity, weight, and type 2 diabetes mellitus

Carbone, Salvatore, O'Keefe, James H. and Lavie, Carl J. (2020). SGLT2 inhibition, visceral adiposity, weight, and type 2 diabetes mellitus. Obesity, 28 (7), 1173-1173. doi: 10.1002/oby.22864

SGLT2 inhibition, visceral adiposity, weight, and type 2 diabetes mellitus

2020

Journal Article

Should atrial fibrillation be considered a cardiovascular risk factor for a worse prognosis in COVID-19 patients?

Sanchis-Gomar, Fabian, Perez-Quilis, Carme and Lavie, Carl J. (2020). Should atrial fibrillation be considered a cardiovascular risk factor for a worse prognosis in COVID-19 patients?. European Heart Journal, 41 (32), 3092-3093. doi: 10.1093/eurheartj/ehaa509

Should atrial fibrillation be considered a cardiovascular risk factor for a worse prognosis in COVID-19 patients?

2020

Journal Article

Personal activity intelligence and mortality – Data from the Aerobics Center Longitudinal Study

Nauman, Javaid, Sui, Xuemei, Lavie, Carl J., Wen, Chi Pang, Laukkanen, Jari A., Blair, Steven N., Dunn, Patrick, Arena, Ross and Wisløff, Ulrik (2020). Personal activity intelligence and mortality – Data from the Aerobics Center Longitudinal Study. Progress in Cardiovascular Diseases, 64, 121-126. doi: 10.1016/j.pcad.2020.05.005

Personal activity intelligence and mortality – Data from the Aerobics Center Longitudinal Study

2020

Journal Article

Clinical features, laboratory characteristics, and outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19): Early report from the United States

Aggarwal, Saurabh, Garcia-Telles, Nelson, Aggarwal, Gaurav, Lavie, Carl, Lippi, Giuseppe and Henry, Brandon Michael (2020). Clinical features, laboratory characteristics, and outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19): Early report from the United States. Diagnosis, 7 (2), 91-96. doi: 10.1515/dx-2020-0046

Clinical features, laboratory characteristics, and outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19): Early report from the United States

2020

Journal Article

Angiotensin-converting enzyme 2 and antihypertensives (angiotensin receptor blockers and angiotensin-converting enzyme inhibitors) in coronavirus disease 2019

Sanchis-Gomar, Fabian, Lavie, Carl J., Perez-Quilis, Carme, Henry, Brandon M. and Lippi, Giuseppe (2020). Angiotensin-converting enzyme 2 and antihypertensives (angiotensin receptor blockers and angiotensin-converting enzyme inhibitors) in coronavirus disease 2019. Mayo Clinic Proceedings, 95 (6), 1222-1230. doi: 10.1016/j.mayocp.2020.03.026

Angiotensin-converting enzyme 2 and antihypertensives (angiotensin receptor blockers and angiotensin-converting enzyme inhibitors) in coronavirus disease 2019

2020

Journal Article

Significance of pulmonary hypertension in hypertrophic cardiomyopathy

Mitra, Anupam, Ghosh, Raktim Kumar, Bandyopadhyay, Dhrubajyoti, Ghosh, Gopal Chandra, Kalra, Ankur and Lavie, Carl J. (2020). Significance of pulmonary hypertension in hypertrophic cardiomyopathy. Current Problems in Cardiology, 45 (6) 100398, 100398. doi: 10.1016/j.cpcardiol.2018.10.002

Significance of pulmonary hypertension in hypertrophic cardiomyopathy

2020

Journal Article

COVID-19 and obesity: links and risks

Lavie, Carl J., Sanchis-Gomar, Fabian, Henry, Brandon Michael and Lippi, Giuseppe (2020). COVID-19 and obesity: links and risks. Expert Review of Endocrinology and Metabolism, 15 (4), 215-216. doi: 10.1080/17446651.2020.1767589

COVID-19 and obesity: links and risks

2020

Journal Article

COVID-19: A time for alternate models in cardiac rehabilitation to take centre stage

Babu, Abraham Samuel, Arena, Ross, Ozemek, Cemal and Lavie, Carl J. (2020). COVID-19: A time for alternate models in cardiac rehabilitation to take centre stage. Canadian Journal of Cardiology, 36 (6), 792-794. doi: 10.1016/j.cjca.2020.04.023

COVID-19: A time for alternate models in cardiac rehabilitation to take centre stage

2020

Journal Article

Heart failure with preserved ejection fraction diagnosis and treatment: An updated review of the evidence

Del Buono, Marco Giuseppe, Iannaccone, Giulia, Scacciavillani, Roberto, Carbone, Salvatore, Camilli, Massimiliano, Niccoli, Giampaolo, Borlaug, Barry A., Lavie, Carl J., Arena, Ross, Crea, Filippo and Abbate, Antonio (2020). Heart failure with preserved ejection fraction diagnosis and treatment: An updated review of the evidence. Progress in Cardiovascular Diseases, 63 (5), 570-584. doi: 10.1016/j.pcad.2020.04.011

Heart failure with preserved ejection fraction diagnosis and treatment: An updated review of the evidence